Göttingen Minipigs in Preclinical Toxicology – a Webinar

//Göttingen Minipigs in Preclinical Toxicology – a Webinar

Göttingen Minipigs in Preclinical Toxicology – a Webinar

The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” Tuesday, June 19, 2012, from 11 am to 12 pm EDT

Register today for “The Other Nonrodent: Göttingen Minipigs in Preclinical Toxicology,” an educational, complimentary webinar hosted by Dr. Scott E. Boley and Ms. Lisa Craig.

Explore the advantages of Göttingen minipigs as an alternative nonrodent model in the development of therapeutics. With this model, multiple delivery routes beyond dermal can be used. Learn about

  • Why many Sponsors choose Göttingen minipigs
  • Why this model is accepted by regulatory authorities

Discover how this well-established model can be used in all aspects of nonclinical research.

Register now!

By |2017-07-04T10:29:14+00:00June 8th, 2012|News|Comments Off on Göttingen Minipigs in Preclinical Toxicology – a Webinar

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.